decisionhealth Newsletters, Part B News - 2021 Issue 9 (September)
Regulatory roundup: Telehealth abuzz in PFS response; CMS kills MCIT, updates No Surprises
Subscribe or sign in to view the full article.
Article Overview
This article reviews several CMS and federal rulemaking updates that were drawing comment and attention around late 2021. It focuses on the Medicare physician fee schedule, telehealth flexibilities, remote therapeutic monitoring, appropriate use criteria, Medicare enrollment and exclusion issues, the proposed repeal of MCIT, and early No Surprises Act enforcement and disclosure rules. The piece is aimed at readers who track Medicare policy, payment regulation, and compliance developments affecting providers and payers.
Why This Topic Matters
These regulatory changes can affect Medicare coverage, billing operations, compliance exposure, and future access to telehealth, remote monitoring, innovative technologies, and surprise-billing protections. The article helps readers track where CMS policy may be heading and which rulemaking areas are likely to affect provider and payer workflows.
Article Sections
-
Comments on the 2022 Medicare physician fee schedule
Overview of public response to the proposed rule and the major themes drawing stakeholder attention. The section frames the broader CMS policy areas under review.
-
Focus on RTM
Discussion of remote therapeutic monitoring as a notable proposal in the fee schedule and the stakeholder interest surrounding its implementation. The section contrasts it with related remote monitoring topics.
-
Au revoir AUC?
Coverage of comments and policy concerns related to appropriate use criteria and its future under Medicare. The section also touches on related advocacy and legislative attention.
-
Beware the enrollment glitch
Summary of proposed Medicare enrollment and exclusion-related changes affecting practices and compliance review. The section explains why commenters saw the issue as significant for providers.
-
Breakthroughs blocked
Explanation of CMS action related to the Medicare Coverage of Innovative Technology rule and the broader debate over coverage for new medical technologies. The section includes stakeholder reactions and the agency’s rationale.
-
No Surprises addendum
Update on early No Surprises Act rulemaking, including provider and payer obligations and enforcement-related provisions. The section also notes state and federal enforcement considerations.
What You Will Learn
- What CMS was reviewing in response to the proposed 2022 Medicare physician fee schedule
- How telehealth and remote therapeutic monitoring were featured in public comments
- What policy areas were being discussed around appropriate use criteria and Medicare enrollment enforcement
- How CMS was approaching the Medicare Coverage of Innovative Technology proposal
- What the early No Surprises Act rules covered and why they matter for compliance
Who Should Read This
- Medical coders
- Billing and reimbursement professionals
- Compliance officers
- Provider practice managers
- Payer policy staff
- Health care attorneys
- Medicare policy analysts
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com